机构:[1]Department of General Surgery, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Heifei 230001, China.[2]Department of Gastrointestinal Surgery, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu 610000 Sichuan, China.四川省人民医院[3]Department of Breast Surgery, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, People’s Hospital of Henan University, Zhengzhou 450000 Henan, China.[4]Microbiome Laboratory, People’s Hospital of Zhengzhou University, Zhengzhou 450000, China.[5]Translational Research Institute, Henan Provincial and Zhengzhou City Key Laboratory of Non-coding RNA and Cancer Metabolism, Henan International Join Laboratory of Non-coding RNA and Metabolism in Cancer, Henan Provincial People’s Hospital, Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450000 Henan, China.[6]Key Laboratory of Stem Cell Differentiation & Modification, School of Clinical Medicine, Henan University, Zhengzhou 450000, China
This study was financially supported by the National Natural Science Foundation of
China (No. 82103543), the China Postdoctoral Science Foundation (No.
2021M693082), Science and technology project of Henan Province(No.
222102310037), Sichuan Science and Technology Program (No. 2023NSFSC1899),
Anhui Provincial Natural Science Foundation (No. 2108085QH340), Henan Province
Medical Science and Technology Project(LHGJ20220018), Medjaden Academy &
Research Foundation for Young Scientists (Grant No. MJR20221014), Key Research
and Development Project of Henan Province (232102521028) and the Fundamental
Research Funds for the Central Universities (No. WK9110000159).
第一作者机构:[1]Department of General Surgery, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Heifei 230001, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Wu Liang,Zhou Zili,Yu Yang,et al.Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression[J].CELL DEATH & DISEASE.2024,15(2):137.doi:10.1038/s41419-024-06526-8.
APA:
Wu Liang,Zhou Zili,Yu Yang,Cheng Can,Zhou Shuai...&Liu Zhengyi.(2024).Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression.CELL DEATH & DISEASE,15,(2)
MLA:
Wu Liang,et al."Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression".CELL DEATH & DISEASE 15..2(2024):137